Nobody here, or least not I, are “attacking” the EXCELLENCE preliminary results, but the trial did not met its primary endpoints, let alone all of them.
There are several ways that can happen and one is a high placebo response, the conclusion is still the same.
Are there signals and hopes, yes some and I have already mentioned those as have others. Clearly not with identical views on approval chances without another trial.
Unfortunately the trial just didn’t go as well as also I expected with a generous 50% chance of success.
News 
Market Data 
Discover 
